Poland· PL-100250805

Medikinet CR 5 mg

A methylphenidate product containing methylphenidati hydrochloridum, registered in Poland by Medice Arzneimittel Puetter GmbH & Co. KG. The same ATC class is registered in 18 of our 19 countries.

ATC N06BA04

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about methylphenidati hydrochloridumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Methylphenidate is registered in 18 of 19 countries.

Countries holding a registration under ATC N06BA04 (methylphenidate), each read from that country’s own register.

This record: Poland, from URPL (Poland)
10 of them publish a price we can compare per daily dose

Search methylphenidate products by name

Methylphenidate · ATC N06BA04

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methylphenidate costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.56 in France to $1.87 in Switzerland — a ×3.4 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Methylphenidate · price per daily dose (30 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.87
IT Italy$0.68
US United States$0.56 (acquisition cost)
FR France$0.56

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Methylphenidati hydrochloridum
Manufacturer: Medice Arzneimittel Puetter GmbH & Co. KG
Country: Poland (PL)
ATC code: N06BA04
ATC class: Methylphenidate
Defined daily dose: 30 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 14

gtin
05909991510329
gtin
05909991510510
gtin
05909991510527
gtin
05909991511241
gtin
05909991511258
gtin
05909990874460
gtin
05909990874477
gtin
05909990874484
gtin
05909991510305
gtin
05909991510312
gtin
05909991512378
gtin
05909991512385
gtin
05909991512392
gtin
05909991525590

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

196 interactions on record for methylphenidate.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check methylphenidate against other medicines How interaction checks work

Methylphenidate · interactions on record

196 records

12 severe
45 moderate
3 minor
128 info

Most severe, free to view

ProcarbazineL01XB01severe
OzanimodL04AA38severe
OzanimodL04AE02severe
CocaineN01BC01severe

8 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methylphenidate in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylphenidate products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Concerta, Conmethyl
Belgium · Atexam 18 Mg, Atexam 27 Mg
Bulgaria · Концерта
Cyprus · Concerta
Czechia · Balipre, Concerta
Germany · 5 Mg, Medikinet, 50 Mg, Medikinet Adult
Denmark · Concerta, Equasym Depot
Estonia · Affenid, Concerta
Spain · Atenza, Concerta
Finland · Atexam, Concerta
France · Concerta Lp, Lp
United Kingdom (Northern Ireland) · Addepta Xl, Affenid Xl
Greece · Concerta
Croatia · Concerta, Mefeda
Hungary · Ritalin, Ritalin La
Ireland · Concerta Xl, Equasym Xl
Iceland · Concerta, Equasym Depot
Italy · Equasym, Medikinet
Liechtenstein · Concerta, Tuzulby
Lithuania · Concerta, Medikinet
Luxembourg · Concerta, Equasym Xr
Latvia · Medikinet, Medikinet Xl
Malta · Concerta, Concerta Xl
Netherlands · Concerta, Equasym Xl
Norway · Concerta, Delmosart
Portugal · Atexam, Concerta
Romania · Clorhidrat De Metilfenidat G.L. Pharma, Concerta
Sweden · Affenid, Concerta
Slovenia · Concerta
Slovakia · Balipre, Concerta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fa1c4165-68b2-4f91-a8aa-45a5b29ae5a8
GET /v1/drugs/fa1c4165-68b2-4f91-a8aa-45a5b29ae5a8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki o zmodyfikowanym uwalnianiu, twarde",
  "source": "urpl",
  "strength": "5 mg",
  "packaging": "05909990874460 ¦ Rpw ¦ 67016\n20 kaps.\n05909990874477 ¦ Rpw ¦ 67017\n30 kaps.\n05909990874484 ¦ Rpw ¦ 67018\n50 kaps.\n05909991510305 ¦ Rpw ¦ 149345\n24 kaps.\n05909991510312 ¦ Rpw ¦ 149346\n27 kaps.\n05909991510329 ¦ Rpw ¦ 149347\n36 kaps.\n05909991510510 ¦ Rpw ¦ 149378\n45 kaps.\n05909991510527 ¦ Rpw ¦ 149379\n48 kaps.\n05909991511241 ¦ Rpw ¦ 149496\n60 kaps.\n05909991511258 ¦ Rpw ¦ 149497\n54 kaps.\n05909991512378 ¦ Rpw ¦ 149724\n99 kaps.\n05909991512385 ¦ Rpw ¦ 149725\n90 kaps.\n05909991512392 ¦ Rpw ¦ 149726\n96 kaps.\n05909991525590 ¦ Rpw ¦ 151934\n63 kaps.",
  "substance": "Methylphenidati hydrochloridum 5 mg",
  "common_name": "Methylphenidati hydrochloridum",
  "pl_product_id": "100250805",
  "pozwolenie_nr": "18355",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about methylphenidate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console